<b>Epicore BioNetworks Inc.</b> Reports Quarter Three Results For Fiscal Year 2017 For The Quarter Ended 31 March 2017, In U.S. Dollars Post author:Sam Post published:May 17, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like This Drug Could be Johnson & Johnson's Next Billion-Dollar Blockbuster January 25, 2017 Boehringer Ingelheim Initiates Phase IIa Study Of Compound Acquired From Pharmaxis In Debilitating Liver Disease NASH August 24, 2017 DexCom Appoints To Board Of Directors March 12, 2017
Boehringer Ingelheim Initiates Phase IIa Study Of Compound Acquired From Pharmaxis In Debilitating Liver Disease NASH August 24, 2017